Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
miR-657
- Development stage
- Preclinical
- Lead developer
- PURMX Therapeutics
- Modality
- MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Subcutaneous, Intratumoral, Transfection
01
Overview
miR-657 is a microRNA-based therapeutic candidate being developed by PURMX Therapeutics for the treatment of solid tumors. As a small RNA nucleic acid drug, it is designed to modulate the activity of miR-657, a microRNA involved in the regulation of gene expression pathways associated with cancer progression. The therapeutic approach aims to leverage the natural RNA interference or gene silencing machinery to inhibit oncogenic signaling or restore tumor-suppressive functions. Currently, the drug is in the basic research stage, with PURMX Therapeutics exploring its potential as a targeted therapy for various solid malignancies.
- Other names
- microRNA-657microRNA657microRNA 657miR-657-miRNAmiR657-miRNAmiR 657-miRNA
02
Targets
miR-657 (microRNA 657)
Beyond the preview
Go deeper on miR-657.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on miR-657.